vTv Therapeutics' Grant - II Round

vTv Therapeutics raised a round of funding on February 15, 2005. Investors include National Institutes of Health.

vTv Therapeutics, formerly TransTech Pharma, is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill signif…

Articles about vTv Therapeutics' Grant - II Round: